RE:RE:RE:RE:RE:Roche CD47 antibody start-up gives up-lays off all employees I think it's time to stop fantasizing about buyouts. Focus should be on news from the company on the effectiveness of what they have. Will there be anything new coming? If not, we will just try to stay afloat